10-Q: DIH Holding US, Inc. Reports Q3 2025 Results: Revenue Up, but Losses Widen Amid Public Company Transition

DIH Holding US, Inc. saw revenue increase but net losses also increased in the third quarter of fiscal year 2025, driven by increased costs associated with becoming a public company.

Summary

• DIH Holding US, Inc. reported revenue of $15.094 million for the three months ended December 31, 2024, compared to $19.011 million for the same period in 2023.
• The company's net loss for the quarter was $3.728 million, compared to a net income of $2.969 million in the prior year.
• For the nine months ended December 31, 2024, revenue was $50.216 million, up from $45.116 million in 2023.
• The net loss for the nine-month period was $4.272 million, compared to a net loss of $2.428 million in the previous year.
• The increased loss is attributed to higher professional service costs and personnel expenses related to becoming a public company, as well as an increase in the fair value of convertible notes and warrant liabilities.
• The company recently closed a debt financing and an equity offering, but substantial doubt remains about its ability to continue as a going concern within one year.
• The company is implementing measures to improve internal controls over financial reporting after identifying material weaknesses.
• The company issued 5,937,100 units at a price of $0.7832 per unit on February 3, 2025, resulting in net proceeds of $3.9 million.
• The company is streamlining its organization and cost structure to improve future revenue growth.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to increased revenue offset by widening losses and concerns about the company's ability to continue as a going concern. The identified material weaknesses in internal controls also contribute to the negative sentiment.

Positives

• Revenue increased by 11.3% for the nine months ended December 31, 2024, compared to the same period in 2023.
• The company is taking steps to streamline its organization and cost structure to improve future revenue growth.
• The company closed an offering of 5,937,100 units at a price of $0.7832 per unit on February 3, 2025, resulting in net proceeds of $3.9 million.
• The company is implementing measures to improve internal controls over financial reporting.

Negatives

• The company's net loss widened to $4.272 million for the nine months ended December 31, 2024, compared to a net loss of $2.428 million in the prior year.
• The company identified material weaknesses in its internal controls over financial reporting.
• Substantial doubt remains about the company's ability to continue as a going concern within one year.
• Revenue for the three months ended December 31, 2024 decreased by $3.9 million, or 20.6%, to $15.1 million from $19.0 million for the three months ended December 31, 2023.

Risks

• The company faces risks related to supply chain disruptions, inflation, and foreign currency fluctuations.
• Changes in laws or regulations, such as the EU MDR, could increase costs and make it more difficult to manufacture, market, and distribute products.
• Macroeconomic uncertainties, including the impact of the conflict in Ukraine, could lead to economic slowdowns.
• The company has material weaknesses in its internal controls over financial reporting.
• The company's future liquidity needs may vary materially from those currently planned and will depend on many factors, including the more aggressive and expansive growth plan, or for any unforeseen reductions in demand, and the availability of debt or equity funding upon terms and conditions acceptable to the Company.

Future Outlook

The company expects revenue to increase sequentially in future periods as it expects the demand for its products to expand in represented markets and is streamlining its organization and cost structure to improve future revenue growth.

Industry Context

The medical rehabilitation device industry is subject to regulatory changes, technological advancements, and macroeconomic factors that can impact company performance. DIH Holding US, Inc. faces competition from other companies in the industry and must adapt to changing market conditions to remain competitive.

Comparison to Industry Standards

• The document does not contain enough information to make a detailed comparison to industry standards.
• A full comparison would require a detailed analysis of the financial results of DIH Holding US, Inc. against those of its competitors, such as Ekso Bionics, ReWalk Robotics, and Hocoma (pre-transfer of assets).
• Key metrics to compare would include revenue growth, gross margin, operating expenses, and net income, as well as market share and product innovation.
• Additionally, it would be important to consider the specific market segments in which DIH Holding US, Inc. operates and the competitive landscape within those segments.

Related Party Transactions

• The company has entered into a distribution agreement with the Motek Group.
• The company incurred three related party notes payable to Hocoma AG.
• During the three and nine months ended December 31, 2024, the Company issued 316,902 shares of Common Stock valued at $450 to members of its Board of Directors as compensation.

Stakeholder Impact

• Shareholders face increased risk due to the company's widening losses and concerns about its ability to continue as a going concern.
• Employees may be affected by the company's efforts to streamline its organization and cost structure.
• Customers may be impacted by supply chain disruptions and changes in product availability.
• Creditors face increased risk due to the company's financial difficulties.

Next Steps

• The company is implementing measures to improve internal controls over financial reporting.
• The company continues to explore financing alternatives in debt or equity to fund its ongoing operations and to fulfill current obligations.
• The company continues to take steps to streamline its organization and cost structure as well as improve future revenue growth.

Key Dates